Evaluate the Efficacy and Safety of Short-term Administration of SIMDAX

NCT03555123 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Decompensated Heart Failure

Interventions

DRUG: Simdax

Sponsor

Yooyoung Pharmaceutical Co., Ltd.